Anaptysbio (ANAB) EPS (Basic) (2016 - 2026)

Anaptysbio (ANAB) posted EPS (Basic) of -$1.84 for Q1 2026, down 205.54% on a QoQ basis from $1.75 in Q4 2025, and down 43.62% year-over-year from -$3.27 in Q1 2025.

Anaptysbio (ANAB) EPS (Basic) (2016 - 2026) Analysis & Trends

Anaptysbio's EPS (Basic) history runs 11 years deep, the most recent figure standing at -$1.84 for Q1 2026.

  • Quarterly EPS (Basic) fell 43.62% year-over-year to -$1.84 in Q1 2026, while the trailing twelve-month figure through Mar 2026 was -$0.91 (up 74.61% YoY) and the FY2025 annual result came in at -$0.44, up 89.14% from the prior year.
  • EPS (Basic) was -$1.84 for Q1 2026 at Anaptysbio, down from $1.75 in the prior quarter.
  • Across five years, EPS (Basic) topped out at $1.75 in Q4 2025 and bottomed at -$2.24 in Q1 2023.
  • A 5-year average of -$1.12 and a median of -$1.41 in 2023 frame the typical range for EPS (Basic).
  • Annual changes were most pronounced in 2023 — EPS (Basic) plunged 94.17% — and 2025, when it soared 468.66%.
  • Anaptysbio's EPS (Basic) stood at -$0.81 in 2022, then plunged by 94.17% to -$1.57 in 2023, then surged by 119.61% to $0.31 in 2024, then surged by 468.66% to $1.75 in 2025, then tumbled by 205.54% to -$1.84 in 2026.
  • Business Quant data shows ANAB's EPS (Basic) at -$1.84 in Q1 2026, $1.75 in Q4 2025, and $0.54 in Q3 2025.

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) EPS (Basic) (Qtr)
1 Oculis Holding AG 67,072.09 Bn 67,072.09 Bn - 0.00
2 Nanobiotix 1,894.61 Bn 1,894.55 Bn - -
3 Akari Therapeutics 1,014.18 Bn 1,014.18 Bn - 0.00
4 BeOne Medicines 471.64 Bn 466.85 Bn 1.35 Bn 0.16
5 Vertex Pharmaceuticals 121.72 Bn 114.47 Bn 2.59 Bn 4.06
6 Regeneron Pharmaceuticals 68.28 Bn 59.52 Bn 3.31 Bn 6.99
7 Belite Bio 61.40 Bn 61.40 Bn - 0.00
8 Argenx Se 56.94 Bn 56.94 Bn 1.18 Bn 5.90
9 Revolution Medicines 37.37 Bn 37.37 Bn - -2.29
10 Anaptysbio 1.55 Bn 1.27 Bn - -1.84

Historic Data

Download Data
DateValue
Mar 31, 2026 -1.84
Dec 31, 2025 1.75
Sep 30, 2025 0.54
Jun 30, 2025 -1.34
Mar 31, 2025 -1.28
Dec 31, 2024 0.31
Sep 30, 2024 -1.14
Jun 30, 2024 -1.71
Mar 31, 2024 -1.64
Dec 31, 2023 -1.57
Sep 30, 2023 -1.41
Jun 30, 2023 -1.50
Mar 31, 2023 -2.24
Dec 31, 2022 -0.81
Sep 30, 2022 -1.33
Jun 30, 2022 -1.81
Mar 31, 2022 -2.03
Dec 31, 2021 -1.17
Sep 30, 2021 -1.23
Jun 30, 2021 -0.96